Bruno Lorusso

7PUBLICATIONS
64CO-AUTHORS
Predictive and prognostic markersMolecular targetsImmunogenetics (incl. genetic immunology)Gene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 10, 2026
PYGO2 is overexpressed in multiple myeloma patients with 1q21 amplification, driving plasma cell proliferation and cell cycle progression.

|May 19, 2026
Inhibition of the Atypical Kinase WNK1 as a Therapeutic Strategy in TAL-related T-cell Acute Lymphoblastic Leukemia.

|Jun 26, 2025
Genetics of Darier's Disease: New Insights into Pathogenic Mechanisms.

Barbara Moschella, Sabrina Busciglio, Enrico Ambrosini

|Dec 13, 2024
Longitudinal Blood Immune-Inflammatory and Radiomic Profiling to Decode Different Patterns of Acquired Resistance to Immunotherapy in Patients with NSCLC.

Giulia Mazzaschi, Cristina Marrocchio, Lucas Moron Dalla Tor

|Sep 28, 2024
CD26 Is Differentially Expressed throughout the Life Cycle of Infantile Hemangiomas and Characterizes the Proliferative Phase.

Bruno Lorusso, Antonella Nogara, Rodanthi Fioretzaki

|Jun 04, 2024
Orthogonal proteogenomic analysis identifies the druggable PA2G4-MYC axis in 3q26 AML.

Matteo Marchesini, Andrea Gherli, Elisa Simoncini

Pageof 2

Frequent Collaborators

6 joint publications

Federico Quaini

4 joint publications

Andrea Gherli

3 joint publications

Costanza Anna Maria Lagrasta

3 joint publications

Gregorio Monica